Beneficient - Class A opened lower at $0.66, compared with its previous close of $0.68. In the last trading session, the stock traded between $0.65 and $0.71. It showed a downward intraday trend.
An investment of $100 made 4 years ago in Beneficient - Class A is now worth
$ 0.01
Resulting in a loss of
$ 99.99 (99.99%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
$-0.02 (-3.48%)
Day High
$0.71
Day Low
$0.65
Day Open
$0.66
Prev Close
$0.68
Volume
90,488
1W Return
-15.12%
1M Return
-31.78%
3M Return
-76.15%
6M Return
-79.97%
1Y Return
-84.21%
Market Cap ($ Mn)
12
PE Ratio
-
PB Ratio
-
PEG Ratio
-
ROE
-
ROCE
6.39%
EPS (TTM)
$-0.46
1 Week
-15.12%
1 Month
-31.78%
3 Months
-76.15%
6 Months
-79.97%
9 Months
-85.14%
Rosen Law investigates Beneficient over misleading business info
Rosen Law Firm is investigating Beneficient for potential securities claims. Allegations center on materially misleading business information issued to investors. Investors may be eligible for compensation via a contingency fee arrangement. Rosen Law Firm cites past success including largest settlement against a Chinese company.
25 days agoRosen Law investigates Beneficient over alleged misleading disclosures
Rosen Law Firm is investigating Beneficient for potential securities claims. Allegations involve materially misleading business information issued to investors. Class action prepared to recover investor losses via contingency fee arrangement. Firm cites past recovery of over $438 million for investors in 2019.
1mo agoRosen Law probes Beneficient as shares drop 51% after debt plan
Beneficient shares fell 51.38% to $1.41 after rising 250.79% previously. Company plans to eliminate $130 million in contested debt linked to former CEO. Rosen Law Firm investigating potential securities claims for misleading information. Equity conversion proposal values $850 million preference into 162,132 shares.
1mo agoBeneficient plans Q4 2026 launch of AltLens risk analytics platform
Beneficient plans to launch AltLens in Q4 2026. Platform targets family offices and small institutions. Tool offers risk analysis and stress-testing capabilities. Private market AUM forecast to reach $29 trillion by 2029.
1mo agoBeneficient Q1 EPS $(0.47) beats estimate; sales up 226% YoY
Beneficient posted Q1 FY27 EPS of $(0.47), beating estimates, while sales of $15.9 million surged 226% YoY. Adjusted operating income turned positive at $5.7 million due to lower expenses.
3mo agoBeneficient registers 55.6 million shares for resale by selling holders
Beneficient registers 55,671,296 Class A common shares for resale, primarily involving Yorkville. The shares include those under a standby equity purchase agreement, convertible notes totaling $4.0 million, commitment fee shares, and warrants exercisable at $21.04.
3mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $1,226.31 | +0.34% | $1,89,370.47M | 27.87 | |
| $42.06 | -0.78% | $93,889.11M | 76.54 | |
| $122.01 | -0.42% | $91,643.54M | 31.85 | |
| $100.05 | -0.79% | $89,258.61M | 34.72 | |
| $52.56 | -1.74% | $83,950.41M | 29.95 | |
| $122.95 | +0.17% | $72,593.74M | 48.40 | |
| $174.17 | +1.49% | $47,387.83M | 17.05 | |
| $520.06 | +0.02% | $45,147.45M | 13.50 | |
| $178.71 | +0.46% | $32,367.60M | 16.05 | |
| $167.13 | -0.58% | $32,088.96M | 15.64 | |
| $137.89 | -1.09% | $30,881.57M | 65.68 | |
| $114.69 | -1.12% | $24,357.40M | 15.87 |
An investment of $100 made 4 years ago in Beneficient - Class A is now worth
$ 0.01
Resulting in a loss of
$ 99.99 (99.99%)
Note: Past profits do not guarantee future returns.
